Skip to content

CTEV CTEV Total debt

Total debt at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$985.43M+13.3%
Corvel logo
CorvelCRVL
$28.11M+0.1%
Phreesia logo
PhreesiaPHR
$98.31M+242%
UnitedHealth Group logo
UnitedHealth GroupUNH
ROP
Roper Technologies, Inc.ROP
Cognizant logo
CognizantCTSH

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total equity-$241.1M-1,727%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B
P/S0.6×

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's total debt?
CTEV (CTEV) reported total debt of $4.66B in Q1 2026.
How has CTEV's total debt changed year-over-year?
CTEV's total debt increased by 1.1% year-over-year, from $4.61B to $4.66B.
What is the long-term trend for CTEV's total debt?
Over 5 years (2020 to 2025), CTEV's total debt has grown at a -0.1% compound annual growth rate (CAGR), from $4.61B to $4.6B.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.